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In this study, we evaluate whether Snail is expressed in adrenocortical cancer (ACC) and if its expression is related to patient
outcome. One of the best known functions of the zinc-finger transcription factor Snail is to induce epithelial-to-mesenchymal
transition (EMT). Increasing evidence suggests that EMT plays a pivotal role in tumour progression and metastatic spread. Snail and
E-cadherin expression were assessed by immunohistochemistry in 26 resected ACCs and real-time quantitative RT–PCR expression
analysis was performed. Data were correlated with clinical outcome and in particular with overall patient survival. Seventeen of
26 (65%) ACC tumour samples expressed Snail when assessed by immunohistochemistry. Snail expression was neither detected
in normal adrenocortical tissue, nor in benign adrenocortical adenomas. Expression levels were confirmed on the mRNA level by
Real-Time–PCR. Survival rates were significantly decreased in Snail-positive tumours compared to Snail-negative tumours: 10 out of
16 vs one out of eight patients succumbed to disease after a median follow up of 14.5 and 28.5 months, respectively (P¼0.03).
Patients with Snail-expressing ACCs presented in advanced disease (11 out of 12 vs 6 out of 14, P¼0.01) and tend to develop
distant metastases more frequently than patients with negative staining (7 out of 11 vs two out of eight, P¼0.19). In conclusion, we
describe for the first time that Snail is expressed in a large subset of ACCs. Furthermore, Snail expression is associated with decreased
survival, advanced disease and higher risk of developing distant metastases.
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Adrenocortical carcinomas (ACCs) derive from the adrenal cortex.
The incidence is about 2 per 1000000 per year and ACCs are
responsible for 0.2% of cancer-related deaths (Wajchenberg et al,
2000). Incidentalomas have been more commonly detected in
recent years, possibly because of the availability and use of better
imaging techniques. Tumours of more than 4cm in diameter carry
an B24% risk of being an ACC (Angeli et al, 1997). The clinical
course and outcome of patients with ACC vary considerably, with
reported overall 5-year survival rates between 38 and 60% (Icard
et al, 2001; Vassilopoulou-Sellin and Schultz, 2001). A recent study
in patients with ACC, which analysed the prognostic factors,
revealed the number of distant metastases, number of invaded
organs and a high mitotic index as predictors of shorter overall
survival (Assie et al, 2007).
The oncogenesis of ACC is poorly understood. Germline
mutations of the tumour supressor p53 and overexpression
of insulin-like growth factor 1 are well known to promote the
development of ACC (Edgren et al, 1997; Ignaszak-Szczepaniak
et al, 2006; Slater et al, 2006).
In epithelial-to-mesenchymal transition (EMT) epithelial cells
show reduced intercellular adhesions and increased mobility,
which is normally restricted to fibroblasts or progenitor cells
during embryonic development (Zhou and Hung, 2005). Numer-
ous studies support the fact that EMT plays a major role in tumour
progression (Zhou and Hung, 2005). During tumour progression,
epithelial cells acquire a gene-expression pattern closely resem-
bling that of mesenchymal cells. In consequence cell motility and
proteolytic potential increase, possibly facilitating invasive growth
and thus contributing to the development of metastases (Thiery
and Sleeman, 2006). A hallmark for EMT is the loss of the cell
adhesion molecule E-cadherin. Downregulation of E-cadherin can
arise – among other mechanisms – through transcriptional
repression. Several EMT regulators have been identified as
E-cadherin repressors, including the zinc-finger transcription factors
Snail (Cano et al, 2000), Slug (Hajra et al, 2002) and Sip1 (smad-
interacting protein 1) (Comijn et al, 2001). Snail is degraded
through the ubiquitin–proteasome pathway if phosphorylated by
glycogen synthase kinase-3b (GSK-3b). Vice versa inhibition of
GSK-3b leads to increased expression level of Snail, to a loss of
E-cadherin and finally to EMT. Loss of E-cadherin is observed in
numerous epithelial tumours and is associated with poorer
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sprognosis (Perl et al, 1998). In a transgenic mouse model of breast
cancer, Snail expression was associated with a more aggressive
phenotype, higher risk of tumour recurrence, and with poor
survival rates (Moody et al, 2005). Snail expression can be induced
by multiple mechanisms, including stimulation by certain
cytokines, for example, epidermal growth factor, fibroblast growth
factor, hepatocyte growth factor, transforming growth factor-b or
as downstream target of the wnt-pathway (Cano et al, 2000; Huber
et al, 2005). These growth factors and transcriptional regulators
are upregulated in ACC which, was observed in microarray
analyses (Giordano et al, 2003; Tissier et al, 2005; Slater et al, 2006)
and might support the impact of EMT in this tumour entity.
Recently, our group described that Snail is overexpressed in a
large subset of neuroendocrine tumours of the ileum, presenting
the first evidence of Snail expression in endocrine tumours
(Fendrich et al, 2007).
The aim of this study was to assess if Snail is expressed in ACC
and if this expression is correlated with clinical outcome and in
particular, with overall survival.
PATIENTS AND METHODS
Patients and pathology
A series of 26 primary ACCs, one liver metastasis and two lymph
node metastases (LNM) of ACCs, were obtained from the tissue
bank of the Department of Pathology, Philipps University of
Marburg, Germany. Histological diagnosis was confirmed by two
experienced pathologists (AR, WS). Histopathological diagnosis
and grading were done in accordance to Weiss, van Slooten and
Hough (Hough et al, 1979; van Slooten et al, 1985; Weiss et al,
1989). Two patients did not reach a score, which indicate
malignancy (P6 and P26), but revealed high Ki67-indexes of
10 and 30%. In addition, they presented with large tumours (130
and 70mm) and showed aldosteron or cortisol and testosteron
excess, respectively. The immunohistochemistry results for Snail
were scored as described earlier (Fendrich et al, 2007): negative¼
less than 5% of tumour cells positive; þ¼o50% of tumour cells
positive; þþ¼450% of tumour cells positive.
To prevent a selection bias we calculated survival curves
for patients with a follow up of more and less than 12 months.
The follow-up period of each patient is listed in Table 1. Ten
functioning, small adenomas from patients with either Cushing’s
or Conn syndrome (see Table 2) served as benign control tumours.
The study protocol met the guidelines of the local ethics
committee.
Surgery and diagnostic work-up
We scheduled patients for surgery if a large tumour suspicious
of ACC with or without hormone excess was found. In case
of distant metastases, patients underwent surgery only to control
the hormone excess. The standard diagnostic work-up is
comprised of thin collimation CT of lung and abdomen. A careful
hormonal assessment was obligate to exclude pheochromocytoma,
subclinical Cushing syndrome and to identify potential tumour
markers.
We used a thoracoabdominal incision and performed an en bloc
resection including the adjacent periadrenal fat and lymph nodes
between the diaphragm, the renal vein and the vena cava, or the
aorta, respectively.
Immunohistochemistry
For immunolabelling, formalin-fixed and paraffin-embedded
archived tumour samples and corresponding normal tissues were
stained as described earlier (Esni et al, 2004). Briefly, slides from
archived ACCs were heated to 601C for 1h, deparaffinised
using xylene, and hydrated by a graded series of ethanol washes.
Antigen retrieval was accomplished by microwave heating in
10mM sodium citrate buffer of pH 6.0 for 10min. For immuno-
histochemistry (IHC), endogenous peroxidase activity was
quenched by 10min incubation in 3% H2O2. Non-specific
binding was blocked with 10% bovine serum. Sections were then
probed with a primary antibody against Snail (Santa Cruz, Santa
Cruz, CA, USA) with a working dilution of 1:100, a primary
antibody against Ki-67 (Dako, Denmark) with a working solution
of 1:200 or a primary antibody for E-cadherin (Zymed, SF, CA,
USA) with a working solution of 1:200, overnight at 41C. The next
day, bound antibodies were detected using the avidin–biotin
complex (ABC) peroxidase method (ABC Elite Kit, Vector Labs,
Burlingame, CA, USA). Final staining was developed with the
Sigma FAST DAB peroxidase substrate kit (Sigma, Deisenhofen,
Germany).
Mammary carcinoma samples from our tissue bank, that had
previously been shown to express high levels of Snail, were used as
positive controls with each batch of Snail IHC staining.
RNA extraction and real-time quantitative PCR
A portion of available fresh frozen tumour tissue was homogenised
and lysed with 600ml buffer RLT and whole RNA was extracted
using the RNeasy kit (Qiagen, Hilden, Germany) with on-column
DNA digestion following the standard protocol provided by
the manufacturer. The mRNA was reverse transcribed into cDNA
with oligo-dT primers using the Superscript 1st Strand System for
RT–PCR (Invitrogen, Carlsbad, CA, USA) at 421C for 50min. All
PCRs were carried out on a 7500 Real-Time PCR System (Applied
Biosystems, Foster City, CA, USA) over 40 cycles, with denatura-
tion for 15s at 951C and combined annealing/extension at 601C for
1min. Following an activation step at 951C for 10min, determina-
tion of Snail mRNA expression was performed over 40 cycles with
15s of denaturation at 951C and annealing/extension/data
acquisition at 601C for 60s using the Power SYBR
s Green PCR
kit (Applied Biosystems).
Primer sequences for Snail were forward: 50-tcccgggcaatttaaca
atg-30 and reverse: 50-tgggagacacatcggtcaga-30. Relative fold mRNA
expression levels were determined using the 2 DDCt method (Livak
KJ et al, 2001) with ribosomal protein, large, P0 (RPLPO)
as housekeeping control. RPLP0 primer sequences were forward
50-tgggcaagaacaccatgatg-30 and reverse 50-agtttctccagagctgggttgt-30.
Statistical analysis
Survival curves were computed from the time of surgical
exploration to either death or most recent contact by using the
Kaplan–Meier method. Log-rank test was applied to identify
significant differences. For analysing proportions a two-tailed
Fisher’s exact test was used. P-values o0.05 were considered as
statistically significant. Data were analysed using SPSS version 14.0
for Microsoft Windows.
RESULTS
Patients
Twenty-six patients (8 male and 18 female) with ACC were
included in this study. The median age of diagnosis was 47.5 years
(range, 15–83 years). Patients were followed for a median period
of 16 months (range, 5–153 months). Out of 26 patients one was
diagnosed at stage I, 13 at stage II, six at stage III and six at stage
IV according to the TNM classification. Six patients presented
with distant metastasis at initial diagnosis, another nine patients
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sdeveloped them during further follow-up. Clinical and histological
data are shown in Table 1.
Clinical data on 10 functioning adenomas, which served as
benign control tumours, is summarised by Table 2.
Expression of Snail
Overall, 17 of 26 (65%) ACC samples revealed positive immuno-
histochemical staining for Snail. Snail expression was inhomo-
geneously distributed in all positive tumour samples, revealing
focal high expression close to the tumour’s capsule in 8 out of
17 ACCs (Figure 1A and B). Seven of 8 of these tumours revealed
a strong expression (þþ) of Snail at the invasive front. As seen in
Figure 1B nearly every single cell along the capsular invasion
showed a positive staining for Snail.
Interestingly, 2 out of 3 metastases (one LNM, one liver
metastasis ) studied showed a strong expression (þþ) of Snail.
Nine of 26 ACCs and one LNM were Snail negative (Figure 2B).
In normal adrenocortical tissue, Snail expression could not be
detected by immunohistochemistry apart from a population of
single cells closed to the adrenal capsule. As expected, adjacent
normal mesenchymal tissue revealed Snail expression and was
used as internal positive control.
These results could be confirmed at the mRNA level on a subset
of 10 samples using quantitative real-time RT–PCR. Normal
adrenocortical tissue and Snail-negative tumours revealed lower
Snail expression levels than þ and þþ classified tumour
samples (Figure 4), P¼0.42. The difference between þ and þþ
tumours was not statistically different.
Snail expression and stage of disease
Snail expression was associated with advanced stage of disease.
Eleven of 12 patients with stage III and IV were Snail positive
whereas only 6 of 14 patients with stage I and II revealed Snail
expression (P¼0.01). Five of six patients presented with
synchronous distant metastases revealed Snail expression in the
primary tumour, whereas only 12 out of 20 patients without
metastases revealed Snail expression without reaching statistical
significance (P¼0.37). On account of the limited number of cases
Snail expression and tumour stage did not show statistical
significance for all stages if analysed separately.
Snail expression, survival and developing of metastases
Survival rates were decreased in Snail-positive tumours in
comparison to Snail-negative tumours: 10 out of 16 vs one out of
eight patients succumbed to the disease after a median follow up of
14.5 (5–132) and 28.5 (6–153) months, respectively (P¼0.03). In
each group of Snail-negative and -positive tumours one unrelated
death occurred and patients were therefore excluded. Survival
curves were calculated including patients with a follow-up of more
Table 1 Clinical characteristics, results of Snail and E-cadherin immunohistochemistry in 26 patients with ACC
Patient no. Age Sex Histo Size/Site TNM Ki-67 (%)
Scoring
(W/VS/H) E-cad IHC Snail IHC
Follow up
(months)
Distant
metastases
1 57 F ACC 200/l III 10 4/9/3.11   ++ NED (132) N
2 43 F ACC 170/r IV 10 6/20/4.52   ++ DOD (14) Y
3 42 M ACC 170/l III 10 5/18/3.13   ++ DOD (41) Y
4 53 F ACC 100/l III 20 4/23.5/1.68   ++ DOD (17) Y
5 73 F ACC 85/l III 1 5/12.3/1.89   ++ DURC (15) N
6 39 F ACC 130/l II 10 2/5.7/1.69   ++ NED (72) N
7 37 F ACC 90/l III 30 5/14.7/4.5   ++ DOD (42) Y
8 46 F ACC 30/r I 10 4/9/2.61 + ++ NED (40) N
9 49 F ACC 70/l II 2 5/13.7/2   ++ NED (14) N
10 72 F ACC 60/l IV 5 7/17.8/3.29   ++ DOD (14) Y
11 26 M ACC 80/r IV 20 ND   ++ DOD (12) Y
12 34 F ACC 120/r III 1 4/14.7/2.29   + DOD (22) Y
13 46 M ACC 105/r IV 10 6/24.2/3.92   + DOD (7) Y
14 50 F ACC 95/r II 5 5/9//4.13   + DOD (17) Y
15 41 M ACC 210/l II 1 7/17.8/3.89   + DOD (11) Y
16 69 M ACC 100/r IV 30 7/20.1/3.52   + AWD (5) Y
17 72 M ACC 95/l II 5 4/10.4/2.6   + NED (5) N
18 24 F ACC 75/r II 3 3/8/1.31 +   NED (6) N
19 22 F ACC 120/r II 1 5/21.1/2.83    DURC (15) N
20 15 M ACC 120/l II 2 5/19.1/2.6    DOD (23) Y
21 72 M ACC 110/r II 5 6/26.8/4.52    AWD (82) Y
22 83 F ACC 120/l II 30 8/26.8/3.89 +   NED (50) N
23 58 F ACC 60/r II 2 4/12.1/2..23    NED (34) N
24 55 F ACC 150/l IV 20 8/26.8/5.21    AWD (12) Y
25 50 F ACC 100/l II 2 4/8/1.68    R(108), NED(153) N
26 43 F ACC 70/l II 20 2/5.7/1.69    NED (6) N
ACC¼Adrenocortical Carcinoma; AWD¼Alive with disease; DURC¼death of unrelated cause; DOD¼Dead of disease; E-cad¼E-cadherin expression; H¼Hough;
IHC¼Immunohistochemistry; NED¼No evidence for disease; VS¼van Slooten; W¼Weiss.
Table 2 Clinical characteristics, results of Snail and E-cadherin
immunohistochemistry in 10 patients with benign adrenocortical adenomas
Pat no. Age Sex Syndrome Size/side E-cad Snail
1 45 F Cush 22/l   
2 33 M Cush 25/l   
3 24 F Cush 30/r +  
4 36 F Cush 20/l +  
5 46 F Cush 15/l   
6 64 F Conn 20/l   
7 49 F Conn 21/r   
8 64 M Conn 15/l +  
9 38 F Conn 15/l   
10 69 M Conn 21/r   
Conn¼Conn syndrome; Cush¼Cushing’s syndrome; E-cad¼E-cadherin expression;
F¼female; l¼left; r¼right; M¼male.
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sand less than 12 months (Figure 5A and B). Indeed both analyses
revealed statistical significance (P¼0.02 and P¼0.01). The
median actuarial survival was 127 months and 34 months for
snail-negative and snail-positive tumours, respectively. The 2- and
5-year survival rate for Snail-negative and Snail-positive tumours
were 100 vs 50%, and 80 vs 20%, respectively.
Patients with Snail-expressing tumours tend to develop distant
metastases more frequently in the subsequent follow up: 7 of
A
B
C
Figure 1 HE staining and IHC staining for Snail and E-cadherin in a
human ACC ( 10). (A) HE staining with tumour invading the surrounding
fatty tissue. (B) Consecutive section with IHC staining for Snail showing
Snail-expressing cells invading the fatty tissue. (C) Same specimen
demonstrating the invasive front at a higher magnification ( 40).
A
B
C
Figure 2 HE staining and IHC staining for Snail and E-cadherin in a Snail-
negative ACC. (A) HE staining showing irregular shaped cells with mitoses.
(B) Cells bared any Snail expression in the IHC. (C) Consecutive section of
(A) and (B) revealing E-caherin expression in some cells indicated by the
dark line associated to the cellular membrane.
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s11 patients developed distant metastases if Snail was expressed by
the tumour, whereas only two of eight patients when Snail
expression of the primary tumour was lacking (P¼0.19).
If Snail-positive tumours classified as þ and þþ were
analysed separately differences, risk of distant metastases, survival
and stage of disease were statistically not significant.
Ki-67 and Snail
Interestingly, we observed the highest median Ki-67 index in
strongly Snail (þþ) expressing ACCs with 10% (range, 1–30) of
cells staining positive for Ki-67. The median Ki-67 index decreases
in Snailþ tumours with 5% (range, 1–10) to reach 2.5% (range,
1–70) in Snail-negative tumours. The differences failed to reach
statistical significance.
E-cadherin expression
Twenty-three of 26 (88%) ACCs did not show any E-cadherin
expression. In three tumour samples, we detect E-cadherin and it
was remarkable that these three patients were without recurrence
after a follow-up of 6, 40, and 50 months, respectively.
Snail and E-cadherin expression in adrenocortical
adenomas
We analysed E-cadherin and Snail expression in 10 adrenocortical
adenomas. Clinical data are shown in Table 2. None of these 10
functioning adenomas (five patients with Cushing and five patients
with Conn syndrome) revealed Snail expression by IHC, and in
only 3 out of 10 we detected E-cadherin expression (see Figure 3A
and B).
DISCUSSION
Local tumour invasion is an early and essential step in the
metastatic cascade. In epithelial tumours, this is often closely
associated with the acquisition of mesenchymal cell-like char-
acteristics; a process termed EMT. One of the hallmarks of EMT is
the functional loss of E-cadherin, which is known to promote cell-
to-cell adhesion and consecutively gives rise to invasion and
progression. The zinc-finger transcription factor Snail is a potent
repressor of E-cadherin and induces EMT. In ovarian, colon,
breast and hepatocarcinoma Snail overexpression has been
observed and resulted in E-cadherin loss. In hepatocarcinoma
and breast cancer, increased Snail expression was associated with
distant metastases and poorer clinical outcome (Miyoshi et al,
2005; Come et al, 2006). In colon and ovarian carcinoma patients
with Snail-expressing tumours, experienced a higher risk for
distant metastases (Elloul et al, 2005; Roy et al, 2005). To the best
of our knowledge, this is the first study of Snail expression in ACCs
and adrenocortical tumours in general.
We found that Snail is expressed in about two-third of a large
series of ACCs. Snail-expressing cells were mostly found at the
invasive front of the ACCs as seen in tumours induced in the skin
of mice (Cano et al, 2000) and recently described by our group in
neuroendocrine tumours of the ileum (Fendrich et al, 2007). At
this site, tumour cells migrate into and invade the surrounding
tissue either as single cells or in collective clusters and give
evidence of an EMT (Zhou et al, 2004). Snail-positive invasive
fronts were observed in 8 of 17 Snail-positive ACCs (Figure 1). In
normal adrenocortical tissue, Snail expression was mostly absent
apart from a distinct cell population close to the capsule
(Figure 3C). We confirmed Snail expression levels by RT–PCR
with cDNA derived from whole tumour samples (Figure 4).
Expression levels correlated with data established by IHC although
A
B
C
Figure 3 IHC for Snail and E-cadherin in an adrenocortical adenoma and
Snail expression in normal adrenal cortex. (A) Adrenal cortical adenoma
showed no Snail expression. Arrow indicates the border between normal
adrenal cortex and adenoma (*). (B) Nor normal adrenocortical tissue
neither adenoma showed any E-cadherin expression in this consecutive
section. (C) Normal adrenocortical tissue was predominantly negative for
Snail, but some single Snail-positive cells within the zona glomerulosa closed
to the capsule and some Snail-positive mesenchymal cells (not shown)
could be detected.
Snail in adrenocortical carcinomas
J Waldmann et al
1904
British Journal of Cancer (2008) 99(11), 1900–1907 & 2008 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sa discrimination of specific tumour regions as invasive areas could
only have been achieved by microdissection.
Remarkably and most importantly, we found that Snail
expression strongly correlates with clinical outcome.
First, Snail expression was associated with an increased risk for
distant metastases. Once a diagnosis of cancer is established, the
urgent and fearful question is whether it is localised or has already
spread to regional lymph nodes and visceral organs. Despite all
improvements in diagnosis, surgery and adjuvant therapies, most
deaths of patients with cancer result from the growth of
metastases. This is also true for ACCs. In this study, seven of 12
patients with Snail-expressing tumours without DM at the initial
diagnosis developed distant metastases, whereas only two of eight
patients developed distant metastases when Snail expression of the
primary tumour was lacking. This is in line with recent reported
studies for other tumour entities, such as breast (Zhou et al, 2004),
ovarian (Elloul et al, 2005), colon (Roy et al, 2005), and squamous
cell carcinoma (Takeno et al, 2004). The first of the many steps
leading to metastasis – the acquisition of local invasiveness
involves major changes in the phenotype of cancer cells within the
primary tumour. To acquire motility and invasiveness, carcinoma
cells must shed many of their epithelial characteristics, detach
from epithelial sheets, and undergo a drastic phenotypic alteration.
Therefore, the expression of Snail represents a specific stage of
tumour progression, preparing tumour cells to invade and to
metastasise, reflected by our findings. In addition, two of three
resected distant metastases expressed Snail, which strongly
supports this hypothesis. Studies in breast carcinoma have shown
similar results (Moody et al, 2005). Recently, it has been proposed
that Snail-mediated tumour recurrence is associated with self-
renewal in cancer stem cell-like cells (De Craene and Berx, 2006).
In this regard, snail expression of single cells in the zona
glomerulosa of normal adrenal cortex close to the organ capsule
(see Figure 3C) may indicate an adrenal stem cell, so called
adrenocyte, which has been proposed by several groups (Skelton,
1959; Belloni et al, 1990; Feige et al, 1998). Thus, our study might
also indicate a role of Snail expression as a prognostic marker in
ACC. Patients with Snail-positive ACCs, but without distant
metastases at initial operation should undergo a very close follow
up, because they might be at a higher risk to develop distant
metastases.
Second, patients with Snail-expressing ACCs were diagnosed
more often in advanced disease, which also underlines that
expression of Snail, could be seen as one of the critical steps in
ACC progression. Eleven of 12 patients with stage III and IV were
Snail positive whereas only 6 of 14 patients with stage I and II
revealed Snail expression (P¼0.01). Because, virtually all patients
with ACC die due to distant metastases, the appearance of Snail
expression probably occurs shortly before invasion and start of
metastasis.
Third, patients with Snail-expressing ACCs had a decreased
survival rate (Figure 5A). Survival rates were significantly lower in
Snail-positive tumours than in Snail-negative tumours (P¼0.02).
In addition, we analysed survival rates for patients with follow-up
longer than 1 year to avoid bias because of missed metastases
during shorter follow up (Figure 5B) and had very similar median
follow up of 14.5 (snail positive) and 28.5 (snail negative) months
in the groups. A decreased survival for patients with Snail-
expressing tumours is in line with recent studies. In ovarian
cancer, a high Snail mRNA expression predicted a shorter
effusion-free survival in ovarian cancer (Elloul et al, 2005). In
node-negative invasive ductal breast carcinomas, Snail mRNA
expression correlated with disease-free and overall survival
(Toyama et al, 2006). The decreased survival in our study might
be either a consequence of the more advanced tumour stage and
the presence of distant metastases in patients with Snail-positive
tumours, or it might reflect an additional aggressiveness of the
tumour cells.
IHC(–) IHC(+) IHC(++)
0.0
0.5
1.0
1.5
2.0
2.5
R
e
l
a
t
i
v
e
 
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
Figure 4 Steady state Snail mRNA levels were determined by real-time
RT–PCR in a subset of 10 samples.
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Figure 5 Kaplan–Meier curve of patients with positive and negative Snail
expression: Note the decreased survival of Snail-expressing ACCs. (A)
Survival in 24 patients with ACC (two were excluded because of disease-
unrelated death), P¼0.02. (B) Survival in 20 patients with ACC (four were
excluded as the follow-up was minor 12 months, two were excluded due
to disease-unrelated death), P¼0.01.
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sOnly 3 of 26 ACCs revealed E-cadherin expression by
immunohistochemistry. Interestingly all three patients were alive
without evidence of metastases or recurrence. The lack of E-
cadherin expression is in line with the overexpression of snail and
indicates EMT in ACC.
Histopathological scoring of adrenocortical tumours provide a
tool for defining malignancy, survival and the risk of metastases as
shown by van’t Sant et al (2007). However, some tumours do not
match all criteria enclosed in the scoring system and therefore do
not reach the threshold for malignancy. Despite these facts two
patients with adrenocortical tumours classified as benign in the
former study developed distant metastases. We enroled three
patients with W and VS of 2 out of 5.7, 3 out of 8 and 2 out of 5.7,
respectively. All patients presented with large (130, 75 and 70mm)
and hormonally active tumours (one Conn Syndrome, two
testosteron and cortisol-producing tumours). They displayed high
Ki-67 indexes of 10, 3 and 30%, respectively. A Ki 67 index of 2.5–
5% is suggestible for an ACC (Wachenfeld et al, 2001; Sasano et al,
2006). Indeed scoring indices could reliably discriminate between
malignant and benign tumours as proven by several studies (van
Slooten et al, 1985; Weiss et al, 1989).
In conclusion, we found that Snail is expressed in a high
proportion of ACCs, which is in line with the concept of EMT.
Furthermore, we show that Snail expression is associated with
decreased survival, advanced disease and tendency of an enhanced
risk for distant metastases, suggesting that the Snail expression
could be used as a prognostic marker in ACC.
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